Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.1.8 (
cholinesterase
)
12,691
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The serotonin type 3A (5-HT
3A
) receptor is a homopentameric cation-selective member of the pentameric ligand-gated ion channel (pLGIC) superfamily. Members of this superfamily assemble from five subunits, each of which consists of three domains: extracellular (ECD), transmembrane (
TMD
), and intracellular domain (ICD). Previously, we have demonstrated that the 5-HT
3A
-ICD is required for the interaction between 5-HT
3A
and the chaperone protein resistance to inhibitors of
choline esterase
(RIC-3). Additionally, we have shown that 5-HT
3A
-ICD fused to maltose-binding protein (MBP) directly interacts with RIC-3, without the involvement of other protein(s). To elucidate the molecular determinants of this interaction, we developed different MBP-fused 5-HT
3A
-ICD constructs by deleting large segments of its amino acid sequence. We expressed seven engineered ICDs in Escherichia coli and purified them to homogeneity. Using a RIC-3 affinity pull-down assay, the interaction between MBP-5HT
3A
-ICD constructs and RIC-3 was investigated. In summary, we identify a 24-amino-acid-long segment of the 5-HT
3A
-ICD as a molecular determinant for the interaction between the 5-HT
3A
-ICD and RIC-3.
...
PMID:Delineating the Site of Interaction of the 5-HT
3A
Receptor with the Chaperone Protein RIC-3. 3187 May 37